Friday 6 November 2026 Export ICLR’s income statement to Excel — free account

ICON PLC

ICLR Healthcare Diagnostics & Research

ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.

Revenue: −2.86%
EPS: +143.2%
Free cash flow: −8.01%
Total debt: −0.86%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

203.49 1.84 +0.91%

Follow ICLR

Alert me

Market cap: $15.1B
P/E: 34.5×
Fwd P/E: 34.6×
Dividend yield: —
F-score: 6/9
Altman Z: 2.01
Beneish M: −2.62
Dividend safety: n/a

Overview

ICON PLC (ICLR) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, ICON PLC (ICLR) trades at a price to free cash flow of 18.1×. Over the past ten years it has ranged from 7.3× (February 2026) to 57.2× (August 2023); the current reading is higher than 28% of that period. That is below the Diagnostics & Research industry median of 33.5× and below the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ICLR/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="ICON PLC price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ICLR/metrics/price-to-free-cash-flow">ICON PLC (ICLR) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	16.6×	7.21%
FY2024	15.5×	(31.56%)
FY2023	22.6×	(39.71%)
FY2022	37.5×	32.61%
FY2021	28.3×	44.55%
FY2020	19.6×	(23.72%)
FY2019	25.6×	(19.27%)
FY2018	31.8×	73.37%
FY2017	18.3×	(3.90%)
FY2016	19.1×	(4.25%)

Period	Price to free cash flow	Change
Sep 2026	15.3×	1.03%
Jun 2026	15.1×	35.26%
Mar 2026	11.2×	(32.64%)
Dec 2025	16.6×	18.05%
43 more quarters	Free account

Against its own ten years

Low 7.3× High 57.2×

Ten-year median 21.3×

Current reading's percentile 28

Company	Price to free cash flow
GH Guardant Health, Inc. compare	n/m
ICLR ICON PLC	18.1×
DGX Quest Diagnostics Incorporated compare	20.3×
QGEN QIAGEN N.V. compare	23.8×
LH Labcorp Holdings Inc. compare	25.4×
MEDP Medpace Holdings, Inc. compare	26.6×
RVTY Revvity Inc. compare	28.2×
ILMN Illumina, Inc. compare	30.4×
CRL Charles River Laboratories International, Inc. compare	37.6×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

ICON PLC (ICLR) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on ICLR

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on ICLR

Stockrow Weekly